340B program

340B operational readiness is the ability for a covered entity to run defensible 340B workflows continuously even as MFP and rebate-related responsibilities increase, because ownership, handoffs, and data quality are strong enough to support execution without constant firefighting. It matters because most failures are not policy misunderstandings, but operational breakdowns that compound when capacity is

Pharmacy Benefit Managers (PBMs) act as intermediaries between health systems, pharmacies, and drug manufacturers, intended to control drug costs through negotiated discounts. However, misaligned incentives, hidden spread pricing, and opaque rebate structures often transform them into significant cost drivers, draining financial resources from 340B Covered Entities and communities. This article examines the systemic issues embedded

Data sovereignty in 340B programs refers to the ability of healthcare covered entities to maintain absolute control, privacy, and ownership over their patient and pharmacy claims data while navigating an increasingly complex web of manufacturer restrictions and federal compliance tracking requirements. As pharmaceutical manufacturers demand more granular data, and as state and federal regulations continuously

340B eligibility requirements for covered entities are designed to ensure that only specific healthcare providers serving vulnerable populations can access discounted drugs. To qualify, an entity must be a federally qualified health center (FQHC), certain hospitals such as disproportionate share hospitals (DSH), children’s hospitals, or other HRSA-recognized safety-net providers. The entity must be officially registered